首页 | 本学科首页   官方微博 | 高级检索  
检索        

雌二醇氮芥联合拉司太特化疗对雄激素抵抗性前列腺癌的疗效分析
引用本文:王阔兴,吴天麟,陈波,王甫剑,张俊杰,韩丛辉,邱祥政,姜波,范涛.雌二醇氮芥联合拉司太特化疗对雄激素抵抗性前列腺癌的疗效分析[J].现代医药卫生,2011,27(16):2407-2408.
作者姓名:王阔兴  吴天麟  陈波  王甫剑  张俊杰  韩丛辉  邱祥政  姜波  范涛
作者单位:徐州市中心医院泌尿外科;
摘    要:目的:探讨雌二醇氮芥联合拉司太特化疗对雄激素抵抗性前列腺癌的疗效。方法:选择12例已进行正规内分泌治疗≥3个疗程,病变呈进展趋势的患者,采用雌二醇氮芥与拉司太特联和化疗。结果:经1~3年随访,8例骨转移者治疗后症状均有不同程度缓解,复查骨扫描好转5例(62.5%),稳定3例(37.5%),中位有效期3个月,中位生存期23个月。结论:采用雌二醇氮芥与拉司太特(VP-16)联和化疗可提高患者生存质量及延长生存期。

关 键 词:前列腺癌  治疗

Clinical analysis on combined chemotherapy of estramustine and lastet for treating hormone-refractory prostate cancer
WANG Kuo-xing,WU Tian-lin,CHEN Bo,WANG Fu-jian,ZHANG Jun-jie,HAN Cong-hui,QIU Xiang-Zheng,JIANG Bo,FAN Tao.Clinical analysis on combined chemotherapy of estramustine and lastet for treating hormone-refractory prostate cancer[J].Modern Medicine Health,2011,27(16):2407-2408.
Authors:WANG Kuo-xing  WU Tian-lin  CHEN Bo  WANG Fu-jian  ZHANG Jun-jie  HAN Cong-hui  QIU Xiang-Zheng  JIANG Bo  FAN Tao
Institution:WANG Kuo-xing,WU Tian-lin,CHEN Bo,WANG Fu-jian,ZHANG Jun-jie,HAN Cong-hui,QIU Xiang-Zheng,JIANG Bo,FAN Tao(Department of Urological Surgery,Central Hospital of Xuzhou,Xuzhou,Jiangsu,221009,China)
Abstract:Objective:To investigate the effect of combined chemotherapy of estramustine and lastet for treating hormone-refractory prostate cancer.Methods:12 patients with hormone-refractory prostate cancer,who received at least three courses of regular endocrine treatment and showed progressive trend,were selected and treated with combined chemotherapy of estramustine and lastet.Results:All the cases were followed up for 1-3 years.8 cases of bony metastasis were relieved to some extent after treatment.Reexamination o...
Keywords:Prostate cancer  Treatment  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号